ESR2 and non-small cell lung carcinoma: Interestingly, a recent in vitro study has highlighted how the protein encoded by the fragile-site associated tumor suppressor (FATS), a novel gene involved in cancer, was able to reduce the proliferation of NSCLC cells through the modulation of autophagic processes by physically interacting with ERβ [129].